Results
|
|
241.
|
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer. [electronic resource] by
- Tamura, Nobumasa
- Horinouchi, Hidehito
- Sekine, Katsutoshi
- Matsumoto, Yuji
- Murakami, Shuji
- Goto, Yasushi
- Kanda, Shintaro
- Fujiwara, Yutaka
- Yamamoto, Noboru
- Ohe, Yuichiro
Producer: 20200630
In:
Thoracic cancer vol. 10
Availability: No items available.
|
|
|
242.
|
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial. [electronic resource] by
- Di Bartolomeo, Maria
- Niger, Monica
- Morano, Federica
- Corallo, Salvatore
- Antista, Maria
- Tamberi, Stefano
- Lonardi, Sara
- Di Donato, Samantha
- Berardi, Rossana
- Scartozzi, Mario
- Cardellino, Giovanni Gerardo
- Di Costanzo, Francesco
- Rimassa, Lorenza
- Luporini, Alberto Gianluigi
- Longarini, Raffaella
- Zaniboni, Alberto
- Bertolini, Alessandro
- Tomasello, Gianluca
- Pinotti, Graziella
- Scagliotti, Giorgio
- Tortora, Giampaolo
- Bonetti, Andrea
- Spallanzani, Andrea
- Frassineti, Giovanni Luca
- Tassinari, Davide
- Giuliani, Francesco
- Cinieri, Saverio
- Maiello, Evaristo
- Verusio, Claudio
- Bracarda, Sergio
- Catalano, Vincenzo
- Basso, Michele
- Ciuffreda, Libero
- De Vita, Ferdinando
- Parra, Hector Soto
- Fornaro, Lorenzo
- Caporale, Marta
- de Braud, Filippo
- Pietrantonio, Filippo
Producer: 20190715
In:
BMC cancer vol. 19
Availability: No items available.
|
|
|
243.
|
|
|
|
244.
|
|
|
|
245.
|
Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer. [electronic resource] by
- Tabernero, Josep
- Ohtsu, Atsushi
- Muro, Kei
- Van Cutsem, Eric
- Oh, Sang Cheul
- Bodoky, György
- Shimada, Yasuhiro
- Hironaka, Shuichi
- Ajani, Jaffer A
- Tomasek, Jiri
- Safran, Howard
- Chandrawansa, Kumari
- Hsu, Yanzhi
- Heathman, Michael
- Khan, Azhar
- Ni, Lan
- Melemed, Allen S
- Gao, Ling
- Ferry, David
- Fuchs, Charles S
Producer: 20180717
In:
Molecular cancer therapeutics vol. 16
Availability: No items available.
|
|
|
246.
|
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer. [electronic resource] by
- Muro, Kei
- Oh, Sang Cheul
- Shimada, Yasuhiro
- Lee, Keun-Wook
- Yen, Chia-Jui
- Chao, Yee
- Cho, Jae Yong
- Cheng, Rebecca
- Carlesi, Roberto
- Chandrawansa, Kumari
- Orlando, Mauro
- Ohtsu, Atsushi
Producer: 20161213
In:
Journal of gastroenterology and hepatology vol. 31
Availability: No items available.
|
|
|
247.
|
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy. [electronic resource] by
- Yoh, Kiyotaka
- Hosomi, Yukio
- Kasahara, Kazuo
- Yamada, Kazuhiko
- Takahashi, Toshiaki
- Yamamoto, Nobuyuki
- Nishio, Makoto
- Ohe, Yuichiro
- Koue, Toshiko
- Nakamura, Takashi
- Enatsu, Sotaro
- Lee, Pablo
- Ferry, David
- Tamura, Tomohide
- Nakagawa, Kazuhiko
Producer: 20171207
In:
Lung cancer (Amsterdam, Netherlands) vol. 99
Availability: No items available.
|
|
|
248.
|
|
|
|
249.
|
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer. [electronic resource] by
- Smit, Egbert F
- Garon, Edward B
- Reck, Martin
- Cappuzzo, Federico
- Bidoli, Paolo
- Cohen, Roger B
- Gao, Ling
- O'Brien, Lisa M
- Lee, Pablo
- Zimmermann, Annamaria
- Ferry, David R
- Melemed, Allen S
- Pérol, Maurice
Producer: 20190625
In:
Cancer chemotherapy and pharmacology vol. 82
Availability: No items available.
|
|
|
250.
|
|
|
|
251.
|
|
|
|
252.
|
|
|
|
253.
|
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial. [electronic resource] by
- Kudo, Masatoshi
- Okusaka, Takuji
- Motomura, Kenta
- Ohno, Izumi
- Morimoto, Manabu
- Seo, Satoru
- Wada, Yoshiyuki
- Sato, Shinpei
- Yamashita, Tatsuya
- Furukawa, Masayuki
- Aramaki, Takeshi
- Nadano, Seijin
- Ohkawa, Kazuyoshi
- Fujii, Hirofumi
- Kudo, Toshihiro
- Furuse, Junji
- Takai, Hiroki
- Homma, Gosuke
- Yoshikawa, Reigetsu
- Zhu, Andrew X
Producer: 20211013
In:
Journal of gastroenterology vol. 55
Availability: No items available.
|
|
|
254.
|
|
|
|
255.
|
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial. [electronic resource] by
- Yoon, H H
- Bendell, J C
- Braiteh, F S
- Firdaus, I
- Philip, P A
- Cohn, A L
- Lewis, N
- Anderson, D M
- Arrowsmith, E
- Schwartz, J D
- Gao, L
- Hsu, Y
- Xu, Y
- Ferry, D
- Alberts, S R
- Wainberg, Z A
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
256.
|
|
|
|
257.
|
|
|
|
258.
|
|
|
|
259.
|
|
|
|
260.
|
|